
Magdalene K. Sgagias
Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 637 |
| Issued Applications | 229 |
| Pending Applications | 42 |
| Abandoned Applications | 366 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9134342
[patent_doc_number] => 20130295056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'Generation of Histocompatible Tissues Using Nuclear Transplantation'
[patent_app_type] => utility
[patent_app_number] => 13/691568
[patent_app_country] => US
[patent_app_date] => 2012-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10767
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13691568
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/691568 | Generation of Histocompatible Tissues Using Nuclear Transplantation | Nov 29, 2012 | Abandoned |
Array
(
[id] => 10051040
[patent_doc_number] => 09090908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-28
[patent_title] => 'Chimeric glycoproteins and pseudotyped lentiviral vectors'
[patent_app_type] => utility
[patent_app_number] => 13/676852
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 9
[patent_no_of_words] => 35015
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676852
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/676852 | Chimeric glycoproteins and pseudotyped lentiviral vectors | Nov 13, 2012 | Issued |
Array
(
[id] => 8842126
[patent_doc_number] => 20130137754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'TUMOR THERAPY WITH REPLICATION COMPETENT SINDBIS VIRAL VECTORS'
[patent_app_type] => utility
[patent_app_number] => 13/644229
[patent_app_country] => US
[patent_app_date] => 2012-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11981
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13644229
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/644229 | TUMOR THERAPY WITH REPLICATION COMPETENT SINDBIS VIRAL VECTORS | Oct 2, 2012 | Abandoned |
Array
(
[id] => 9841289
[patent_doc_number] => 20150033371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'HAIR FOLLICLE STEM CELLS AND METHODS OF USE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/344898
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 23273
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344898
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344898 | HAIR FOLLICLE STEM CELLS AND METHODS OF USE SAME | Sep 12, 2012 | Abandoned |
Array
(
[id] => 9053956
[patent_doc_number] => 20130251670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/615043
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9213
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13615043
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/615043 | Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof | Sep 12, 2012 | Abandoned |
Array
(
[id] => 10946376
[patent_doc_number] => 20140349396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'Compositions and Methods Relating to Clonal Progenitor Cells'
[patent_app_type] => utility
[patent_app_number] => 14/238160
[patent_app_country] => US
[patent_app_date] => 2012-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 32042
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238160
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/238160 | Compositions and Methods Relating to Clonal Progenitor Cells | Sep 9, 2012 | Abandoned |
Array
(
[id] => 8684443
[patent_doc_number] => 20130052727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'COMPOSITIONS AND METHODS FOR AUTOLOGOUS GERMLINE MITOCHONDRIAL ENERGY TRANSFER'
[patent_app_type] => utility
[patent_app_number] => 13/606914
[patent_app_country] => US
[patent_app_date] => 2012-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 22335
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13606914
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/606914 | Compositions for autologous ovarian oogonial stem cell mitochondrial energy transfer | Sep 6, 2012 | Issued |
Array
(
[id] => 8698070
[patent_doc_number] => 20130060079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR AUTOLOGOUS GERMLINE MITOCHONDRIAL ENERGY TRANSFER'
[patent_app_type] => utility
[patent_app_number] => 13/590812
[patent_app_country] => US
[patent_app_date] => 2012-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 22081
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13590812
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/590812 | Compositions and methods for autologous germline mitochondrial energy transfer | Aug 20, 2012 | Issued |
Array
(
[id] => 8483285
[patent_doc_number] => 20120282692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'Oocytes Derived from Ovarian Culture Initially Containing No Oocytes'
[patent_app_type] => utility
[patent_app_number] => 13/551685
[patent_app_country] => US
[patent_app_date] => 2012-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5415
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13551685
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/551685 | Oocytes Derived from Ovarian Culture Initially Containing No Oocytes | Jul 17, 2012 | Abandoned |
Array
(
[id] => 8482937
[patent_doc_number] => 20120282344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'FORMULATION FOR THE BIOLOGICAL CONTROL OF INSECT-PESTS'
[patent_app_type] => utility
[patent_app_number] => 13/548563
[patent_app_country] => US
[patent_app_date] => 2012-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7805
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13548563
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/548563 | FORMULATION FOR THE BIOLOGICAL CONTROL OF INSECT-PESTS | Jul 12, 2012 | Abandoned |
Array
(
[id] => 8464616
[patent_doc_number] => 20120269784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'CARDIAC MUSCLE REPAIR OR REGENERATION USING BONE MARROW-DERIVED STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/540021
[patent_app_country] => US
[patent_app_date] => 2012-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7942
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13540021
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/540021 | Cardiac muscle repair or regeneration using bone marrow-derived stem cells | Jul 1, 2012 | Issued |
Array
(
[id] => 9204895
[patent_doc_number] => 20140004072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'Polyethyleneimine And Beta2-Adrenergic Receptor Based Gene Therapy For Acute Lung Injury'
[patent_app_type] => utility
[patent_app_number] => 13/539300
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 6247
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539300
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/539300 | Polyethyleneimine And Beta2-Adrenergic Receptor Based Gene Therapy For Acute Lung Injury | Jun 28, 2012 | Abandoned |
Array
(
[id] => 8441467
[patent_doc_number] => 20120258083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'PLACENTAL VASCULAR LOBULE STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/527579
[patent_app_country] => US
[patent_app_date] => 2012-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3120
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13527579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/527579 | PLACENTAL VASCULAR LOBULE STEM CELLS | Jun 18, 2012 | Abandoned |
Array
(
[id] => 8670987
[patent_doc_number] => 20130045525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'METHOD OF CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/524503
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 14834
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524503
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/524503 | Method of cancer treatment | Jun 14, 2012 | Issued |
Array
(
[id] => 8585641
[patent_doc_number] => 20130004462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'MODIFIED FACTOR VIII AND FACTOR IX GENES AND VECTORS FOR GENE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/494068
[patent_app_country] => US
[patent_app_date] => 2012-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 10498
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13494068
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/494068 | Modified factor VIII and factor IX genes and vectors for gene therapy | Jun 11, 2012 | Issued |
Array
(
[id] => 9449401
[patent_doc_number] => 20140120571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'PRODUCTION METHOD FOR ARTIFICIAL CANCER STEM CELL AND INDUCED DIFFERENTIATION METHOD THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/122634
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8247
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122634
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122634 | Production method for artificial cancer stem cell and induced differentiation method therefor | May 23, 2012 | Issued |
Array
(
[id] => 17968467
[patent_doc_number] => 11485984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Method for introducing hepatocyte growth factor and neurogenin 1 into mesenchymal stem cells
[patent_app_type] => utility
[patent_app_number] => 14/119788
[patent_app_country] => US
[patent_app_date] => 2012-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 7784
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14119788
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/119788 | Method for introducing hepatocyte growth factor and neurogenin 1 into mesenchymal stem cells | May 22, 2012 | Issued |
Array
(
[id] => 8683882
[patent_doc_number] => 20130052166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'MATERIALS AND METHODS FOR MINIMALLY-INVASIVE ADMINISTRATION OF A CELL-CONTAINING FLOWABLE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/467180
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18609
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467180
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467180 | MATERIALS AND METHODS FOR MINIMALLY-INVASIVE ADMINISTRATION OF A CELL-CONTAINING FLOWABLE COMPOSITION | May 8, 2012 | Abandoned |
Array
(
[id] => 8358595
[patent_doc_number] => 20120213749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'CARDIAC MUSCLE REGENERATION USING MESENCHYMAL STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/454315
[patent_app_country] => US
[patent_app_date] => 2012-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6712
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454315
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/454315 | CARDIAC MUSCLE REGENERATION USING MESENCHYMAL STEM CELLS | Apr 23, 2012 | Abandoned |
Array
(
[id] => 9510927
[patent_doc_number] => 20140147418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'AAV MEDIATED CTLA-4 GENE TRANSFER TO TREAT SJOGREN\'S SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 14/111604
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17580
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111604
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111604 | AAV MEDIATED CTLA-4 GENE TRANSFER TO TREAT SJOGREN'S SYNDROME | Apr 12, 2012 | Abandoned |